DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We identified three mutations of TBX1 in two unrelated patients without the 22q11.2 deletion-one with sporadic conotruncal anomaly face syndrome/velocardiofacial syndrome and one with sporadic DiGeorge's syndrome-and in three patients from a family with conotruncal anomaly face syndrome/velocardiofacial syndrome.
|
14585638 |
2003 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates.
|
19531352 |
2009 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Chromosome 22q11 deletion or CATCH 22 is associated with DiGeorge syndrome, conotruncal anomaly face syndrome, and velocardiofacial syndrome.
|
9986884 |
1999 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The DiGeorge/velocardiofacial syndrome (DGS/VCFS) is a relatively common human disorder, usually associated with deletions of chromosome 22q11.
|
11242110 |
2001 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
These include the 3-Mb region commonly deleted in DiGeorge/velocardiofacial syndrome (DGS/VCFS), the cat eye syndrome (CES) region, and more distal regions in 22q11 that have recently been shown to be deleted.
|
18033723 |
2008 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
LHGDN |
Genetic dissection of the DiGeorge syndrome phenotype.
|
12858556 |
2002 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Here, the genetic pathways regulating cardiac neural crest development are reviewed and the evidence implicating TBX1 and other genes on chromosome 22q11 in the pathogenesis of DiGeorge syndrome is summarized.
|
11585671 |
2001 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
This was associated with middle and inner ear malformations, analogous to Mondini dysplasia in humans reported to occur in VCFS/DGS patients.
|
11709542 |
2001 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
By providing functional data to indicate loss-of-function produced by the 1223delC TBX1 mutation, our results provide strong support for the conclusion that TBX1 mutations can cause DGS in humans.
|
15703190 |
2005 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract.
|
15175244 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Mouse studies have shown that the Tbx1 gene is haploinsufficient, as expected for a DGS candidate gene, and that it is required for the development of pharyngeal arches and pouches, as predicted by the DGS clinical phenotype.
|
11971873 |
2002 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The 22q11.2 deletion syndrome (22q11.2DS; velo-cardio-facial syndrome; DiGeorge syndrome) is a congenital anomaly disorder in which haploinsufficiency of TBX1, encoding a T-box transcription factor, is the major candidate for cardiac outflow tract (OFT) malformations.
|
28346476 |
2017 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
PRODH maps to 22q11 in the region deleted in the velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS) and encodes proline oxidase (POX), a mitochondrial inner-membrane enzyme that catalyzes the first step in the proline degradation pathway.
|
15662599 |
2005 |
DiGeorge Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
We identified three mutations of TBX1 in two unrelated patients without the 22q11.2 deletion-one with sporadic conotruncal anomaly face syndrome/velocardiofacial syndrome and one with sporadic DiGeorge's syndrome-and in three patients from a family with conotruncal anomaly face syndrome/velocardiofacial syndrome.
|
14585638 |
2003 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
To support this idea further, we identified a family that carries an interstitial duplication of the same 3 Mb region that is deleted in VCFS/DGS patients.
|
10369860 |
1999 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.
|
11242110 |
2001 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome).
|
9801257 |
1998 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Our data show that haploinsufficiency of Tbx1 is sufficient to generate at least one important component of the DiGeorge syndrome phenotype in mice, and demonstrate the suitability of the mouse for the genetic dissection of microdeletion syndromes.
|
11242049 |
2001 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants.
|
16696966 |
2006 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We showed that inactivation of Bmp4 from Tbx1-expressing cells leads to the spectrum of deformities resembling the cardiovascular defects observed in human DiGeorge syndrome patients.
|
21123999 |
2011 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The low-copy repeat (LCR) is a new class of repetitive DNA element and has been implicated in many human disorders, including DiGeorge/velocardiofacial syndrome (DGS/VCFS).
|
16307865 |
2006 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We identified three mutations of TBX1 in two unrelated patients without the 22q11.2 deletion-one with sporadic conotruncal anomaly face syndrome/velocardiofacial syndrome and one with sporadic DiGeorge's syndrome-and in three patients from a family with conotruncal anomaly face syndrome/velocardiofacial syndrome.
|
14585638 |
2003 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This report describes a newborn girl presenting with some of the common features of DiGeorge syndrome/velocardiofacial syndrome (DGS/VCFS), including hypocalcemia, atrial septal defect, and aortic stenosis.
|
30799418 |
2019 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
DiGeorge/velocardiofacial syndrome (DGS/VCFS) is a disorder caused by a 22q11.2 deletion mediated by non-allelic homologous recombination (NAHR) between low-copy repeats (LCRs).
|
28059126 |
2017 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mutations in human T-box genes TBX3, TBX5, and TBX1 cause severe genetic disorders known as Ulnar-Mammary syndrome (UMS), Holt-Oram syndrome (HOS), and DiGeorge syndrome, respectively.
|
12005433 |
2002 |